Literature DB >> 11567528

A simplified reconstitution of mRNA-directed peptide synthesis: activity of the epsilon enhancer and an unnatural amino acid.

A C Forster1, H Weissbach, S C Blacklow.   

Abstract

The study of the early events in translation would be greatly facilitated by reconstitution with easily purified components. Here, Escherichia coli oligopeptide synthesis has been reconstituted using five purified recombinant His-tagged E. coli initiation and elongation factors. Highly purified ribosomes are required to yield products with strong dependencies on the translation factors. Based on HPLC separation of radiolabeled translation products from an mRNA encoding a tetrapeptide, approximately 80% of peptide products are full length, and the remaining 20% are the dipeptide and tripeptide products resulting from pausing or premature termination. Oligopeptide synthesis is enhanced when a commonly used epsilon (enhancer of protein synthesis initiation) sequence is included in the mRNA. The system incorporates a selectable, large, unnatural amino acid and may ultimately form the basis of a pure translation display technology for the directed evolution of peptidomimetic ligands and drug candidates. The recombinant clones can be exploited to prepare initiation factors and initiation complexes for structural studies, to study initiation and elongation in ribosomal peptide synthesis, and to screen for eubacterial-specific drugs. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567528     DOI: 10.1006/abio.2001.5329

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  18 in total

1.  Programming peptidomimetic syntheses by translating genetic codes designed de novo.

Authors:  Anthony C Forster; Zhongping Tan; Madhavi N L Nalam; Hening Lin; Hui Qu; Virginia W Cornish; Stephen C Blacklow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

2.  In vitro selection for sense codon suppression.

Authors:  Adam Frankel; Richard W Roberts
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

3.  Specificity of translation for N-alkyl amino acids.

Authors:  Baolin Zhang; Zhongping Tan; Lucas Gartenmann Dickson; Madhavi N L Nalam; Virginia W Cornish; Anthony C Forster
Journal:  J Am Chem Soc       Date:  2007-08-25       Impact factor: 15.419

4.  Multiplexed in vivo His-tagging of enzyme pathways for in vitro single-pot multienzyme catalysis.

Authors:  Harris H Wang; Po-Yi Huang; George Xu; Wilhelm Haas; Adam Marblestone; Jun Li; Steven P Gygi; Anthony C Forster; Michael C Jewett; George M Church
Journal:  ACS Synth Biol       Date:  2012-02-17       Impact factor: 5.110

5.  Directed Evolution of Glycopeptides Using mRNA Display.

Authors:  Satoru Horiya; Jennifer K Bailey; Isaac J Krauss
Journal:  Methods Enzymol       Date:  2017-08-18       Impact factor: 1.600

6.  Changeability of individual domains of an aminoacyl-tRNA in polymerization by the ribosome.

Authors:  Rong Gao; Anthony C Forster
Journal:  FEBS Lett       Date:  2010-01-04       Impact factor: 4.124

7.  Enzymatic aminoacylation of tRNA with unnatural amino acids.

Authors:  Matthew C T Hartman; Kristopher Josephson; Jack W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 8.  Protease-resistant peptide design-empowering nature's fragile warriors against HIV.

Authors:  Matthew T Weinstock; J Nicholas Francis; Joseph S Redman; Michael S Kay
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

9.  Engineering multigene expression in vitro and in vivo with small terminators for T7 RNA polymerase.

Authors:  Liping Du; Rong Gao; Anthony C Forster
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

10.  The roles of initiation factor 2 and guanosine triphosphate in initiation of protein synthesis.

Authors:  Ayman Antoun; Michael Y Pavlov; Kerstin Andersson; Tanel Tenson; Måns Ehrenberg
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.